Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Therapeutic Innovation & Regulatory Science|December 1, 2020
Evaluating the Feasibility of Electronic Health Records and Claims Data Sources for Specific Research PurposesMary E Ritchey, Cynthia J GirmanClinical Therapeutics|October 5, 2023
Can Weight of Evidence, Quantitative Bias, and Bounding Methods Evaluate Robustness of Real-world Evidence for Regulator and Health Technology Assessment Decisions on Medical Interventions?Emma M Rosen, Mary E Ritchey, Cynthia J GirmanTherapeutic Innovation & Regulatory Science|June 4, 2025
Real-World Evidence in FDA Approvals for Labeling Expansion of Small Molecules and BiologicsYung-Fang Deng, Cynthia J Girman, Mary E RitcheyArchives of Internal Medicine|April 29, 2009
Effect of a pharmacist on adverse drug events and medication errors in outpatients with cardiovascular diseaseMichael D Murray, Mary E Ritchey, Jingwei Wu, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 6, 2022
Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature ReviewSarah Dahlberg, Ellen T Chang, Sheila R Weiss, et al.Journal of Neurology|April 1, 2021
A systematic review and meta-analyses on the prevalence of pregnancy outcomes in migraine treated patients: a contribution from the IMI2 ConcePTION projectDaniel C Dudman, Fatima Tauqeer, Moninder Kaur, et al.Therapeutic Innovation & Regulatory Science|January 28, 2021
Demonstrating that Real World Evidence Is Fit-For-Purpose to Support Labeling: Parallels to Patient Reported Outcomes in the Pursuit of Labeling ClaimsCynthia J Girman, Mary E Ritchey, Ann Marie McNeill, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 7, 2015
Characterization of Sitagliptin Use in Patients with Type 2 Diabetes and Chronic Kidney Disease by Cross-Sectional Analysis of a Medical Insurance Claims DatabaseKimberly G Brodovicz, Yong Chen, Zhiwen Liu, et al.Neurology and Therapy|May 17, 2023
Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort StudyJ Bradley Layton, Mary E Ritchey, Zhongwen Huang, et al.Cancer Treatment and Research Communications|July 17, 2020
Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of TrastuzumabMichelle D Hackshaw, Christine L Bui, Amy Ladner, et al.Pageof 4